Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8SO5T
|
|||
| Drug Name |
RNS60
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 2 | [1] | |
| Multiple sclerosis [ICD-11: 8A40] | Phase 2 | [2] | ||
| Company |
Revalesio
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03456882) The Effect of RNS60 on ALS Biomarkers (RNS60). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01714089) Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.